Stories
-
Crisp, the platform for demand forecasting the food supply chain, gets $12 million in funding
Crisp, a demand forecasting platform for the food industry, has today announced the close of a $12 million Series A…
Read More » -
Texas county approves tax breaks for possible Tesla Cybertruck factory
Texas is moving forward with efforts to woo Tesla Inc. and lure its next electric-vehicle factory after the county that’s…
Read More » -
Pizza delivery made a comeback during coronavirus lockdowns. Investors worry the hunger won’t last
Americans on lockdown have rediscovered delivery pizza, giving once shaky brands like Pizza Hut and Papa John’s a boost. But…
Read More » -
Brave Robot ice cream launches as the first brand from the Perfect Day-backed Urgent Company
The founders of the alternative dairy protein manufacturer, Perfect Day, have joined with a longtime product developer in the dairy…
Read More » -
Hetero starts the supply of a generic version of Remdesivir – A Coronavirus Drug ‘Covifor’
Remdesivir is the first drug shown to help fight COVID-19. It reduces the recovery time of the COVID patient. The…
Read More » -
Why the U.S. needs international students – Trumps Administration scraps new visa order for many foreign students
Last week, Trump gave a very clear-headed message for all the international students in the U.S, saying that they wouldn’t…
Read More » -
Biocon’s Itolizumab, COVID-19 drug got approved by DGCA; just after 30 human trials…
Drugs Controller General of India (DCGI) approved biopharmaceuticals company Biocon’s Itolizumab (ALZUMAb) which is a plaque psoriasis drug as an…
Read More » -
Google to pick 7.7 pc stake in Jio for Rs 33,737 crore
Google will pick up 7.7 per cent stake in Reliance Industries’ technology venture for Rs 33,737 crore, richest Indian Mukesh…
Read More » -
Jio developing homegrown 5G telecom solution: Ambani
Richest Indian Mukesh Ambani on Wednesday announced his group’s digital arm Jio developing a homegrown 5G telecom solution. “Jio has…
Read More » -
Favipiravir Approved as Anti- COVID-19 Drug; DCGI Approves Influenza Treatment Drug For Covid-19 Treatment In India
Behind the drugs: The Drug Controller General of India has approved the use of favipiravir – an antiviral drug commonly…
Read More »